5Hernandez-Diaz Sonia, Arbogast Patrick G, Dudley Judith A, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatric and perinatal epidemiology, 2009,23 ( 1 ): 18-28.
6Diav-Citrin Orna, Shechtman Svetlana, Tellem, Rotem,et al. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study. European journal of obstetrics, gynecology, and reproductive biology, 2008,141(1):31-34.
5Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
6Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
7Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
8Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
9Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
3Cooper WO,Hemandez-Diaz S.Arbogast PG,et al.Antibiotics pOtcntially used in response to bioterrorism and the risk of major congenital malformations[J].Paedialric and Perinatal Epidemiology,2009,23(1):18-28.